MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Collegium Pharmaceutical Company Profile (NASDAQ:COLL)

Consensus Ratings for Collegium Pharmaceutical (NASDAQ:COLL) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $27.20 (63.36% upside)

Analysts' Ratings History for Collegium Pharmaceutical (NASDAQ:COLL)
Show:
DateFirmActionRatingPrice TargetActions
5/26/2016Needham & Company LLCReiterated RatingBuy$28.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Piper JaffrayReiterated RatingOverweight$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Janney Montgomery ScottInitiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016William BlairInitiated CoverageOutperform$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Jefferies GroupInitiated CoverageBuy$20.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha